Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights

Stock Information for Poseida Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Poseida Therapeutics Inc.

Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HRZN, RKDA, HNI on Behalf of Shareholders
$HAREHOLDER ALERT: The M&A Class Action Launches Legal Inquiry for the Merger - HRZN, HNI, GDST, and RKDA
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, BASE, RKDA on Behalf of Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq - HLVX), Steelcase Inc. (NYSE - SCS), LAVA Therapeutics N.V. (Nasdaq - LVTX), Arcadia Biosciences, Inc. (Nasdaq - RKDA)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, FUBO, RKDA, NSC on Behalf of Shareholders
URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - OLO, FUBO, RKDA, and NSC

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.